Trump’s Research Rule Proposal Sparks Debate
A new rule proposed by the Trump administration is causing alarm among various groups. Patient organizations, scientists, lawmakers from all political backgrounds, and pharmaceutical companies have all expressed concerns. They argue this proposition could politicize scientific grant funding and harm biomedical research leadership in the United States.
The White House Office of Management and Budget (OMB) has introduced this rule, which has attracted nearly 342,000 public comments as of the deadline on Monday. Most comments oppose the changes. The OMB intends to finalize the rule by October 1. If enacted, this rule would standardize policies previously attempted through executive orders and at agency levels. All discretionary government grants would require review by senior officials, with the possibility of denial based on the president’s agenda. Existing grants might be canceled without clear reasons and with limited options for appeal.
Implications of the Proposed Rule
The proposed rule includes significant restrictions. It seeks to ban grants contingent on research in diversity, equity, and inclusion, alongside gender considerations. It also aims to limit international scientific collaborations. This is significant, as China’s swift rise in the field threatens America’s status as a leader in biomedical research.
The administration justifies the proposal as a necessity for enhancing transparency and curbing waste, fraud, and abuse across government sectors. However, 57 patient advocacy groups, representing many Americans with chronic or acute diseases, urged Congress to prevent the rule’s enactment. Known as United for Cures, these groups argue the rule would compromise the country’s global scientific leadership, potentially impacting ongoing clinical trials and wasting federal investments.
Healthcare Developments in Washington
Nathaniel Weixel and Joseph report on events affecting healthcare policies in Washington in The Hill’s Healthcare newsletter. Recent developments include a report by the Department of Health and Human Services (HHS) Office of Inspector General, which highlighted $5.56 billion in projected savings over six months and the exclusion of over 1,200 entities from federal programs.
Also in the news, the sudden death of Senator Lindsey Graham at age 71 was due to an aortic dissection, raising awareness about the severity of this condition. Furthermore, a second U.S. citizen contracted Ebola, necessitating medical evacuation to Germany.
Recent Legal Actions
A coalition of state attorneys general is taking legal action against the Department of Education (DOE). The suit challenges the alleged unlawful termination of mental health grants for public school students. This follows an injunction from a federal judge on the department’s decision to cut funds.
Healthcare Initiatives Nationwide
Various state and local healthcare news updates include efforts and challenges within Medicaid spending, the closure of school-based health clinics in Virginia due to funding issues, and Missouri’s governor signing a bipartisan healthcare bill into law.
For more updates, stay tuned for The Hill’s Healthcare newsletter.